Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group-Reference-Cited by-同舟云学术

Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group

Published:2020-05 Issue:2 Volume:157 Page:312-322
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Miller David Scott^ORCID,Randall Marcus E.,Filiaci Virginia^ORCID

Funder

NIH

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference66 articles.

1. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study;Creasman;Cancer,1987

2. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study;Morrow;Gynecol. Oncol.,1991

3. Significance of true surgical pathologic staging: a Gynecologic Oncology Group study;Creasman;Am. J. Obstet. Gynecol.,1999

4. Pathologic indicators of prognosis in endometrial adenocarcinoma. Selected aspects emphasizing the GOG experience. Gynecologic Oncology Group;Zaino;Pathol. Annu.,1995

5. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system: a Gynecologic Oncology Group study;Zaino;Cancer,1995

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial;Journal of Clinical Oncology;2022-03-20

2. Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy;Journal of Cancer;2022

3. Endometriumkarzinom: Anthrazyklinfreies Therapieregime zeigt weniger Toxizitäten und bessere gesundheitsbezogenen Lebensqualität;Kompass Onkologie;2021

4. Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209);Journal of Clinical Oncology;2020-11-20

5. Prognostic Implications of Immune-Related Genes’ (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer;Frontiers in Genetics;2020-07-21